Seroprevalence of Chagas disease at the Instituto Nacional de Cardiología Ignacio Chávez from 2004 to 2010




Diana V. Reséndiz-Solís, Facultad Ciencias de la Salud, Universidad Tecnológica de México Campus Sur (UNITEC Sur), Iztapalapa, Ciudad de Méxic, México
Alejandro Ruiz-Sánchez, Departamento de Nutrición Universidad Univermilenium, Plantel Ecatepec, Ecatepec de Morelos, Estado de México, México
Martha A. Ballinas-Verdugo, Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Ciudad de México, México


Background: Different pathogens can cause dilated cardiomyopathy, one of them is Trypanosoma cruzi protozoan. T.cruzi-chronic infection causes chronic Chagasic cardiomyopathy and affects the sinus node and the conduction systembelow the bundle of His; besides, it shows excellent arrhythmogenic potential because of ventricular arrhythmias. Knowingthe clinical characteristics and performing serological tests to diagnose chronic Chagasic cardiomyopathy is essential. The serological diagnosis for searching the antibodies is based on the phase, which can be a predictor for the development of dilated cardiomyopathy. Objectives: In this work, the objective was to describe the frequency of dilated cardiomyopathy in patients with T. cruzi positive serology. Method: A total of 961 patients who were medically and clinically diagnosed with dilated cardiomyopathy were studied. Of these, 128 were diagnosed with chronic Chagasic cardiomyopathy and had positive serology for T. cruzi with two serological tests. Results: The clinical findings were obtained from the results of the electrocardiograms and were taken from the patient’s clinical histories. Conclusion: In conclusion, complete blockage of the right branch of the bundle of His (44.2%) is one of the primary conduction disorders in the patients studied. Regarding seroprevalence, 14% of patients diagnosed with dilated cardiomyopathy had anti-T. cruzi antibodies.



Keywords: Trypanosoma cruzi. Chagasic chronic cardiomyopathy. Chagas disease. Antibodies serological diagnosis.